Picture Kentro Design Corporate and Web Design Berlin 600x60px
Financing › Details

Themis Bioscience–SEVERAL: investment, 201810– IPO €35m to €55.3m on Euronext Amsterdam POSTPONED 11/18


Period Period 2018-10-29
  Predecessor Themis Bioscience–SEVERAL: investment, 201801 financing round Series C €10m led by new investor GHIF
Organisation Money taker Themis Bioscience N.V.
  Group Themis Bioscience (Group)
Products Product Measles Vector (MV) technology platform
  Product 2 investment banking
Document Source Themis Bioscience N.V.. (10/29/18). "Press Release: Themis Bioscience Launches its Initial Public Offering on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna.

Record changed: 2018-11-12


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Themis Bioscience (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top